jueves, 14 de julio de 2016

Health.mil - Army researchers, Sanofi Pasteur to co-develop Zika virus vaccine

Health.mil - Army researchers, Sanofi Pasteur to co-develop Zika virus vaccine

Health.mil



Army researchers, Sanofi Pasteur to co-develop Zika virus vaccine

A digitally-colorized transmission electron micrograph of Zika virus, which is a member of the family Flaviviridae. Virus particles, here colored blue, are 40 nanometers in diameter with an outer envelope and an inner dense core.

A digitally-colorized transmission electron micrograph of Zika virus, which is a member of the family Flaviviridae. Virus particles, here colored blue, are 40 nanometers in diameter with an outer envelope and an inner dense core. Zika virus is spread to people through mosquito bites. The most common symptoms of Zika virus disease are fever, rash, joint pain and conjunctivitis, or red eyes. The illness is usually mild with symptoms lasting from several days to a week. Severe disease requiring hospitalization is uncommon. (Centers for Disease Control and Prevention photo by Cynthia Goldsmith)





THe Walter Reed Army Institute of Research and the vaccines division of Sanofi Pasteur have agreed to co-develop a Zika virus vaccine based on initial work by WRAIR scientists and collaborators at Beth Israel Deaconess Medical Center in Boston. 
According to a recent WRAIR press release, Army scientists and their collaborators are moving quickly to develop and test the vaccine candidate, which builds on a vaccine platform developed by WRAIR scientists for other flaviviruses, including Japanese encephalitis and dengue. 
When this work is complete, the recently signed cooperative research and development agreement will allow the transfer of the Zika purified inactivated virus, or ZPIV, technology to Sanofi to explore advanced and larger-scale manufacturing and production. 
The platform, said Army Col. Stephen Thomas, an infectious diseases physician, vaccinologist and the WRAIR Zika program lead, “has been proven to be safe, effective and able to meet regulatory requirements of the U.S. Food and Drug Administration.” 
Vaccine is Feasible 
As part of the agreement, WRAIR and collaborators will share data related to assays that measure antibody responses after vaccination with ZPIV, biologic samples generated during animal studies, and biologic samples generated during early human trials that assess ZPIV safety and immunogenicity, WRAIR officials said. 
Preclinical work on the vaccine is being conducted with long-term HIV vaccine collaborators at the Beth Israel Deaconess Medical Center, a teaching affiliate of Harvard Medical School. 
A preclinical study in mice, published June 28 in “Nature,” showed that a single dose of ZPIV generated an immune response that protected the mice against a Zika challenge with a Brazilian strain of the virus. 
“The preclinical work gives us early confidence that development of a protective Zika virus vaccine for humans is feasible,” Army Col. Nelson Michael, the WRAIR Zika program co-lead, said. 
Initial ZPIV supplies are being manufactured by the WRAIR’s Pilot Bioproduction Facility in Silver Spring, Maryland. The National Institute of Allergy and Infectious Diseases will provide regulatory sponsorship for the initial human trials, WRAIR officials said. 
WRAIR researchers plan to start human testing at their Clinical Trials Center before the end of the year. At the same time, NIAID will begin more studies through its Vaccine Trials and Evaluation Units. 
Growing Concern 
According to the World Health Organization, as of June 29, 61 countries and territories have now reported continuing mosquito-borne transmission. Of these, 47 countries are experiencing a first outbreak of Zika virus since 2015, and 14 reported evidence of Zika virus transmission between 2007 and 2014, with ongoing transmission. 
For the United States and its territories, during a press call this morning by public health experts and congressional leaders on the need for Zika funding, Centers for Disease Control and Prevention Director Dr. Tom Frieden said the more scientists learn about Zika the more concerned they are. 
“It is now definitively confirmed that Zika does cause not only microcephaly but also other severe brain defects,” he said, and that it can cause such defects whether a person who is infected has symptoms or not. 
In the continental United States, he added, travel-associated cases now stand at more than 1,130, including 320 pregnant women. 
In U.S. territories the number of diagnosed and reported locally acquired cases stands at 2,526, including 279 pregnant women, Frieden said, noting that in Puerto Rico CDC is seeing “a rapid increase in the level of infection such that we think that each day dozens, and potentially as many as 50, more pregnant women [there] are becoming infected with Zika virus.” 
At WRAIR, Thomas says infectious diseases have long been a threat to U.S. service members and that the military has extensive expertise and capabilities for developing countermeasures. 
“The WRAIR has been studying flaviviruses for over 100 years,” he added, “since Walter Reed and his team discovered that yellow fever is transmitted by mosquitoes.” 
Disclaimer: Re-published content may have been edited for length and clarity. Read original post.




Predicting contagiousness to limit the spread of disease

Article
7/12/2016
Following exposure to a pathogen, people may become infected, and soon after they may begin to spread disease to others. Some people become infected and also become sick with symptoms (red). Some people become infected and do not exhibit symptoms, but still spread disease (yellow). Some people do not become infected (blue).
Prometheus seeks to discover a minimal set of molecular biomarkers that would indicate, less than 24 hours after exposure to a pathogen, whether an individual will become contagious
Related Topics: Research and Innovation | Innovation

Incoming DHA Research and Development director brings new perspective

Article
7/7/2016
Rear Adm. Colin Chinn, director of Research, Development & Acquisition, for the Defense Health Agency
Meet Navy Rear Adm. Colin Chinn as the director of Research, Development & Acquisition (RDA), for the Defense Health Agency.
Related Topics: Research and Innovation | Innovation

USU students learn public health, zombie style

Article
7/5/2016
An animated zombie pandemic scenario helps students in the family nurse practitioner doctorate of nursing practice program at the Uniformed Services University of the Health Sciences to understand key principles in responding to and understanding population health – the overall health of a group, be it a group of employees, a community, or entire nation. USHS graphic
An animated zombie pandemic scenario helps students in the family nurse practitioner doctorate of nursing practice program at the Uniformed Services University of the Health Sciences to understand key principles in responding to and understanding population health.
Related Topics: Public Health | Health Readiness

Medical Surveillance Monthly Report: Volume 23, Number 6

Report
7/1/2016
Medical Surveillance Monthly Report
Related Topics: Health Readiness | Armed Forces Health Surveillance Branch | Public Health

Pathogen reduction technology funding approved, ASBP on the forefront of deployment

Article
6/27/2016
The Armed Services Blood Bank Center at the Walter Reed National Military Medical Center in Bethesda, Md., received a new state-of-the-art blood mobile May 5.
The U.S. Department of Health and Human Services has agreed to provide more than $48 million to fund pathogen reduction technologies
Related Topics: Armed Services Blood Program | Zika Virus | Innovation

MHS experts offers summer advice from fighting bugs to knowing where to go for medical help

Article
6/23/2016
Warmer weather naturally draws more people to pools, lakes, rivers and the ocean. Keep an eye on each other, especially children. He said despite soaking in water, people can become dehydrated. (U.S. Marine Corps photo by Cpl. Charles Santamaria)
Whether it’s keeping bugs away or knowing how to get help, check out these tips to have safer summer vacation travel.
Related Topics: Summer Safety | Mosquito-Borne Illnesses | Preventing Mosquito-Borne Illnesses | Chikungunya | Dengue | Zika Virus

Mosquito Bite Prevention

Infographic
6/23/2016
infographic about mosquito bite prevention
Follow these steps to reduce your chances of getting bitten
Related Topics: Mosquito-Borne Illnesses | Preventing Mosquito-Borne Illnesses

Chikungunya Infection Among MHS Beneficiaries in the Western Hemisphere

Infographic
6/22/2016
Infographic about chikungunya infection among DoD beneficiaries in the western hemisphere
This infographic describes the number of Chikunguna cases among DoD beneficiaries reported through the Disease Reporting System Internet (DRSi). It also describes signs and symptoms of Chikunguna infection.
Related Topics: Armed Forces Health Surveillance Branch | Preventing Mosquito-Borne Illnesses | Chikungunya | Mosquito-Borne Illnesses

Naval Health Research Center launches norovirus vaccine trial

Article
6/22/2016
Navy Petty Officer 2nd Class Sterling Wold, a hospital corpsman in Naval Hospital Camp Pendleton's Family Medicine Immunizations Clinic, gives a shot to a patient. Extensive safety testing for this potential norovirus vaccine has been performed in civilian populations, but because the recruit training population regularly experiences large outbreaks of norovirus, it is a perfect place to test the effectiveness of the vaccine for the military. (U.S. Navy photo by Hospital Corpsman 2nd Class Markian R. Carreon)
Currently, there is no vaccine to prevent norovirus, a highly contagious disease which causes vomiting and diarrhea
Related Topics: Health Readiness | Immunization Healthcare | Medical Research and Development

Zika Virus and Pregnancy

Infographic
6/21/2016
infographic about Zika virus and pregnancy
Zika can cause certain birth defects. This infographic offers information to pregnant women about how to protect themselves from the Zika virus.
Related Topics: Preventing Mosquito-Borne Illnesses | Zika Virus | Mosquito-Borne Illnesses

Zika Virus and Sexual Transmission

Infographic
6/21/2016
infographic about sexual transmission of the Zika virus
Zika virus can be spread by a man with Zika to his sex partners. This infographic provides tips for avoiding sexual transmission of the Zika virus.
Related Topics: Preventing Mosquito-Borne Illnesses | Zika Virus | Mosquito-Borne Illnesses

Planning a trip?

Infographic
6/17/2016
Infographic about planning ahead to protect against mosquito borne illness on a trip
Do your homework to protect yourself from mosquito-borne illnesses
Related Topics: Mosquito-Borne Illnesses | Preventing Mosquito-Borne Illnesses

Help Control Mosquitoes that Spread Viruses Like Zika, Dengue, and Chikungunya

Infographic
6/17/2016
Infographic about preventing Mosquitoes
Mosquito-borne illnesses are a major public health concern. Follow these tips to help control mosquitoes around your home and in your community.
Related Topics: Mosquito-Borne Illnesses | Preventing Mosquito-Borne Illnesses

U.S. Army Institute of Surgical Research looking for eye injury treatment

Article
6/17/2016
Army Capt. Elaine Por, a principle investigator and deputy task area manager in the Ocular Trauma Division at the USAISR, is looking for a novel way to treat eye injuries that can result in blindness.
A non-invasive treatment could be available to Wounded Warriors with eye injuries within the next two to three years
Related Topics: Conditions and Treatments | Quality and Safety of Health Care | Research and Innovation | Vision Loss

Walter Reed scientists test Zika vaccine candidate

Article
6/10/2016
This photograph depicts a female Aedes aegypti mosquito, the species of mosquito primarily responsible for the spread of the Zika virus disease to people.
As mosquitoes carrying the Zika virus spread illness to people across the Americas and beyond, scientists at Walter Reed Army Institute of Research are moving quickly
Related Topics: Zika Virus | Mosquito-Borne Illnesses

No hay comentarios:

Publicar un comentario